Related content

A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer

By Sousa Alejandro   Inman Brant A.   Piñeiro Idelfonso   Monserrat Victor   Pérez Alberto   Aparici Vincente   Gómez Isabel   Neira Pilar   Uribarri Carlos  

International Journal of Hyperthermia, Vol. 30, Iss. 3, 2014-05 ,pp. : 166-170

Informa Healthcare

Access to resources Recommend Favorite

Maintenance Therapy with Intravesical Bacillus Calmette-Guérin in Patients with Intermediate- or High-risk Non-muscle-invasive Bladder Cancer

By Muto Satoru   Nakajima Akiko   Horiuchi Akira   Inoue Masayuki   China Toshiyuki   Saito Keisuke   Isotani Shuji   Hisasue Shin-ichi   Yamaguchi Raizo   Ide Hisamitsu   Horie Shigeo  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 3, 2013-03 ,pp. : 305-313

Oxford University Press

Access to resources Recommend Favorite

The Efficacy of Intravesical Bacillus Calmette-Guerin in the Treatment of Patients with pT1 Stage Non-muscle-invasive Bladder Cancer

By Ajili Faouzia  

Ultrastructural Pathology, Vol. 37, Iss. 4, 2013-08 ,pp. : 278-283

Informa Healthcare

Access to resources Recommend Favorite

Monthly intravesical bacillus Calmette-Guérin maintenance therapy for non-muscle-invasive bladder cancer: 10-year experience in a single institute

By      

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 221-225

Spandidos Publications

Access to resources Recommend Favorite

Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer

By Ke Hung-Lung  

Carcinogenesis, Vol. 34, Iss. 5, 2013-05 ,pp. : 1006-1011

Oxford University Press

Access to resources Recommend Favorite